skip to main content

H.R. 1222: Congenital Heart Futures Reauthorization Act of 2017

Call or Write Congress

About the bill

Source: Republican Policy Committee

H.R. 1222 would direct the Secretary of Health and Human Services (HHS), through the Centers for Disease Control and Prevention (CDC), to enhance surveillance capabilities to track the epidemiology of congenital heart disease (CHD) and to provide grants to study the epidemiology of CHD across the lifespan. In addition, the legislation would require the Secretary report to Congress on CHD, including information on the demographics and health care utilization of individuals with the disease. Additionally, the bill would reauthorize research on CHD at the National Institutes of Health (NIH ...

Sponsor and status

Gus Bilirakis

Sponsor. Representative for Florida's 12th congressional district. Republican.

Read Text »
Last Updated: Aug 15, 2018
Length: 12 pages
Introduced:

Feb 27, 2017

Status:

Passed House (Senate next) on Feb 26, 2018

This bill passed in the House on February 26, 2018 and goes to the Senate next for consideration.

Prognosis:

16% chance of being enacted according to Skopos Labs (details)

What stakeholders are saying

Institute for Spending Reform: SpendingTracker.org estimates H.R. 1222 will add $18 million in new spending through 2023.

History

Feb 27, 2017
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

May 18, 2017
 
Considered by Health

A committee held a hearing or business meeting about the bill.

Jun 7, 2017
 
Ordered Reported

A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

Sep 25, 2017
 
Reported by House Committee on Energy and Commerce

A committee issued a report on the bill, which often provides helpful explanatory background on the issue addressed by the bill and the bill's intentions.

Feb 26, 2018
 
Passed House (Senate next)

The bill was passed in a vote in the House. It goes to the Senate next.

Jul 25, 2018
 
Considered by Senate Committee on Health, Education, Labor, and Pensions

A committee held a hearing or business meeting about the bill.

Aug 15, 2018
 
Text Published

Updated bill text was published as of Reported by Senate Committee.

If this bill has further action, the following steps may occur next:
 
Passed Senate

 
Signed by the President

H.R. 1222 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 1222 — 115th Congress: Congenital Heart Futures Reauthorization Act of 2017.” www.GovTrack.us. 2017. October 15, 2018 <https://www.govtrack.us/congress/bills/115/hr1222>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.